Generation and validation of a prognostic score to predict outcome after re-irradiation of recurrent glioma

References

• Combs SE, Thilmann C, Edler L, Debus J, Schulz-Ertner D. Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: Long-term results in 172 patients treated in a single institution. J Clin Oncol 2005;23:8863–9.
   PubMed Web of Science ®Google Scholar
• Bauman GS, Sneed PK, Wara WM, Stalpers LJ, Chang SM, McDermott MW, . Reirradiation of primary CNS tumors. Int J Radiat Oncol Biol Phys 1996;36:433–41.
   PubMed Web of Science ®Google Scholar
• Arcicasa M, Roncadin M, Bidoli E, Dedkov A, Gigante M, Trovo MG. Reirradiation and lomustine in patients with relapsed high-grade gliomas. Int J Radiat Oncol Biol Phys 1999;43:789–93.
   PubMed Web of Science ®Google Scholar
• Combs SE, Gutwein S, Thilmann C, Debus J, Schulz-Ertner D. Reirradiation of recurrent WHO grade III astrocytomas using fractionated stereotactic radiotherapy (FSRT). Strahlenther Onkol 2005;181:768–73.
   PubMed Web of Science ®Google Scholar
• Fokas E, Wacker U, Gross MW, Henzel M, Encheva E, Engenhart-Cabillic R. Hypofractionated stereotactic reirradiation of recurrent glioblastomas: A beneficial treatment option after high-dose radiotherapy? Strahlenther Onkol 2009;185:235–40.
   PubMed Web of Science ®Google Scholar
• Henke G, Paulsen F, Steinbach JP, Ganswindt U, Isijanov H, Kortmann RD, . Hypofractionated reirradiation for recurrent malignant glioma. Strahlenther Onkol 2009;185: 113–9.
   PubMed Web of Science ®Google Scholar
• Pollack IF. Neuro-oncology: Therapeutic benefits of reirradiation for recurrent brain tumors. Nat Rev Neurol 2010;6:533–5.
   PubMed Web of Science ®Google Scholar
• Rasmussen KH, Hardcastle N, Howard SP, Tome WA. Reirradiation of glioblastoma through the use of a reduced dose rate on a tomotherapy unit. Technol Cancer Res Treat 2010;9:399–406.
   PubMed Web of Science ®Google Scholar
• Park JK, Hodges T, Arko L, Shen M, Dello ID, McNabb A, . Scale to predict survival after surgery for recurrent glioblastoma multiforme. J Clin Oncol 2010; 28:3838–43.
   PubMed Web of Science ®Google Scholar
• Karger CP, Hipp P, Henze M, Echner G, Hoss A, Schad L, . Stereotactic imaging for radiotherapy: Accuracy of CT, MRI, PET and SPECT. Phys Med Biol 2003;48:211–21.
   PubMed Web of Science ®Google Scholar
• Wong ET, Hess KR, Gleason MJ, Jaeckle KA, Kyritsis AP, Prados MD, . Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials. J Clin Oncol 1999;17:2572–8.
   PubMed Web of Science ®Google Scholar
• Wick A, Pascher C, Wick W, Jauch T, Weller M, Bogdahn U, . Rechallenge with temozolomide in patients with recurrent gliomas. J Neurol 2009;256:734–41.
   PubMed Web of Science ®Google Scholar
• Wick A, Felsberg J, Steinbach JP, Herrlinger U, Platten M, Blaschke B, . Efficacy and tolerability of temozolomide in an alternating weekly regimen in patients with recurrent glioma. J Clin Oncol 2007;25:3357–61.
   PubMed Web of Science ®Google Scholar
• Barker FG, Chang SM, Gutin PH, Malec MK, McDermott MW, Prados MD, . Survival and functional status after resection of recurrent glioblastoma multiforme. Neurosurgery 1998;42:709–20.
   PubMed Web of Science ®Google Scholar
• Niyazi M, Ganswindt U, Schwarz SB, Kreth FW, Tonn JC, Geisler J, . Irradiation and bevacizumab in high-grade glioma retreatment settings. Int J Radiat Oncol Biol Phys 2012;82:67–76.
   PubMed Web of Science ®Google Scholar
• Dirks P, Bernstein M, Muller PJ, Tucker WS. The value of reoperation for recurrent glioblastoma. Can J Surg 1993;36:271–5.
   PubMed Web of Science ®Google Scholar
• Combs SE, Widmer V, Thilmann C, Hof H, Debus J, Schulz-Ertner D. Stereotactic radiosurgery (SRS): Treatment option for recurrent glioblastoma multiforme (GBM). Cancer 2005;104:2168–73.
   PubMed Web of Science ®Google Scholar
• Mayer R, Sminia P. Reirradiation tolerance of the human brain. Int J Radiat Oncol Biol Phys 2008;70:1350–60.
   PubMed Web of Science ®Google Scholar
• Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, . Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 2009;10:459–66.
   PubMed Web of Science ®Google Scholar
• Combs SE, Wagner J, Bischof M, Welzel T, Edler L, Rausch R, . Radiochemotherapy in patients with primary glioblastoma comparing two temozolomide dose regimens. Int J Radiat Oncol Biol Phys 2008;71:999–1005.
   PubMed Web of Science ®Google Scholar